Proven efficacy in both laboratory studies and real-world settings

ActivePure® is THE technology proven to reduce pathogens in the air and on surfaces in real-time.

Devices with ActivePure Technology have been proven against a wide-range of pathogens

Aspergillus niger (endospore; Toxic Black surrogate)

H1N1 (Swine Flu; Influenza A virus)

Mycobacterium tuberculosis (TB)

Aspergillus versicolor (fungus)

H5N8 (Bird Flu; Influenza A virus)

Phi-X174 (DNA bacteriophage virus)

Bacillus globigii (bacterial endospore; Anthrax surrogate)

Legionella pneumophila (Gram- bacteria)

Respiratory syncytial virus (RSV)

Botrytis cinerea (fungus)

Listeria monocytogenes (Gram+ bacteria)

Salmonella enterica (Gram- bacteria)

Candida auris (fungus)

Methicillin-Resistant Staphylococcus aureus (MRSA; Gram+ bacteria)

SARS-CoV-2

Clostridioides difficile (C. diff; endospore)

Monkeypox virus (MPXV)

Sclerotinia sclerotiorum (fungus)

Erwinia herbicola (Gram- bacteria)

MS2 (RNA bacteriophage virus)

Staphylococcus aureus (Gram+ bacteria)

Escherichia coli (E. coli; Gram- bacteria)

Murine Norovirus (virus)

Staphylococcus epidermis (Gram+ bacteria)

See full list

Hide

Testing done on multiple devices with ActivePure Technology, excluding the ActivePure Medical Guardian, at multiple 3rd party labs. Please contact us for specific testing results and/or additional testing information.

ActivePure® Technology is scientifically proven to be ≥ 99.9% effective against:

A Pyramid showing the hierarchy of pathogens and their resistance starting from bottom (easiest resistance) to top (hardest resistance); Enveloped Viruses, Bacteria, Fungi, Non-enveloped viruses, mycobacteria, and spores.

To learn more about the hierarchy of pathogens, review Dr. William Rutala’s Overview of Current Disinfection Hierarchy Models.

Spores

Bacillus Globigii (Spore)

(Same category as Clostridioides Difficile)

Mycobacteria

Testing completed against harder pathogens

(Mycobacterium tuberculosis)

Non-Enveloped Viruses

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Fungi

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Bacteria

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria) (Same category as MRSA, VRE & Acinetobacter)

Enveloped Viruses

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

Bacillus Globigii (Spore)

(Same category as Clostridiodes Difficile)

Testing completed against harder pathogens

(Category of Mycobacterium Tuberculosis)

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)

(Same category as MRSA, VRE & Acinetobacter)

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

A Pyramid showing the hierarchy of pathogens and their resistance starting from bottom (easiest resistance) to top (hardest resistance); Enveloped Viruses, Bacteria, Fungi, Non-enveloped viruses, mycobacteria, and spores.

To learn more about the hierarchy of pathogens, review Dr. William Rutala’s Overview of Current Disinfection Hierarchy Models.

Spores

Bacillus Globigii (Spore)

(Same category as Clostridioides Difficile)

Mycobacteria

Testing completed against harder pathogens

(Mycobacterium tuberculosis)

Non-Enveloped Viruses

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Fungi

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Bacteria

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)

(Same category as MRSA, VRE & Acinetobacter)

Enveloped Viruses

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

Bacillus Globigii (Spore)

(Same category as Clostridiodes Difficile)

Testing completed against harder pathogens

(Category of Mycobacterium Tuberculosis)

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)

(Same category as MRSA, VRE & Acinetobacter)

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

ActivePure Medical Guardian testing for FDA Class II Clearance

60-minute average pathogen reduction chart using ActivePure Technology to treat a room.

60-Minute average pathogen reduction percent

Graph showing a reduction of >99.9999% for RNA viruses and >99.993% for DNA viruses within 60 minutes of installing ActivePure Medical Guardian.

Testing done on the ActivePure Medical Guardian at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage.

60-Minute average pathogen reduction percent

Chart showing a reduction in gram-negative and positive bacteria of >99.99% within 60 minutes of installing ActivePure.

Testing done on the ActivePure Medical Guardian at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Gram-positive Bacteria: Staphylococcus Epidermidis. Gram-negative Bacteria: Erwinia Herbicola.

60-Minute average pathogen reduction percent

Chart showing removal of 99.99% fungal and bacterial mold within 6o minutes of using ActivePure Medical Guardian.

Testing done on the ActivePure Medical Guardian at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Fungal Mold: Apergillus Niger. Bacterial Mold: Bacillus Globigii.

Testing done on the ActivePure Medical Guardian at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage. Gram-positive Bacteria: Staphylococcus epidermidis. Gram-negative Bacteria: Erwinia herbicola. Fungal Mold: Aspergillus niger. Bacterial Mold: Bacillus globigii.

Peer-reviewed science

ActivePure is committed to the highest scientific standards, with multiple published peer-reviewed studies and more in progress. The first was a study published in the American Journal of Infection Control (AJIC) on healthcare-associated infection (HAI) reduction. This study is on the pioneering edge of demonstrating that continuous decontamination can reduce surface, floor, and air contaminants and thereby reduce the acquisitions of HAIs. A summary of those results is available here.

The second study was also published by AJIC and focused on ActivePure’s efficacy against SARS-CoV-2, respiratory syncytial virus (RSV), and monkeypox virus. The results of the study highlight ActivePure’s potential as a valuable tool for improving indoor air quality and infection control. A summary of those results is available here.

Our third published peer-reviewed study was published in PLOS ONE. It examined the impact of ActivePure Technology on lab mice using the same concentrations of ActivePure proven effective against viral, bacterial, and fungal pathogens. This study showed that there were no statistically significant differences between the test group and control group due to exposure to ActivePure. A summary of those results is available here.

Learn More